Pancreatic Cancer Research

ResearcherFirst Hospital of China Medical UniversityActive in the last 2 years

Xi Zoë Zhong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0713-105X; OpenAlex author ID A5109066915. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Moracin D suppresses cell growth and induces apoptosis via targeting the XIAP/PARP1 axis in pancreatic cancer. Co-author DOI 10.1016/j.phymed.2024.155527↗
  2. Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review. First author DOI 10.3389/fonc.2020.01466↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongjuan Cui · 1 shared paper, 2024 · strength 0.22
  2. Bolun Jiang · 1 shared paper, 2020 · strength 0.13
  3. Li Zhou · 1 shared paper, 2020 · strength 0.13
  4. Jun Lü · 1 shared paper, 2020 · strength 0.13
  5. Yizhi Wang · 1 shared paper, 2020 · strength 0.13
  6. Junchao Guo · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.